InsiderTrades

Form 4 for SANA Sana Biotechnology, Inc.

Accepted 2026-08-27 16:21:33 ET · period of report 2026-08-26 · accession 0002115339-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-27 16:21 2026-08-26 SANA PATEL DHAVALKUMAR DHIRAJLAL EVP, CSO M - OptEx $0.00 +125.0K 224.5K +126% $0
D 2026-08-27 16:21 2026-08-27 SANA PATEL DHAVALKUMAR DHIRAJLAL EVP, CSO F - Tax $4.11 -41.2K 183.4K -18% -$169.2K
D 2026-08-27 16:21 2026-08-26 SANA PATEL DHAVALKUMAR DHIRAJLAL EVP, CSO M - OptEx $0.00 -125.0K 250.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-26 M A 125,000 $0.00 224,510 D — —
2 Common Common Stock 2026-08-27 F D 41,158 $4.11 183,352 D — —
3 Derivative Restricted Stock Units 2026-08-26 M D 125,000 $0.00 250,000 D — · — to — 125,000 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Sana Biotechology, Inc. ("Sana") common stock. (F2) The award vested as to 25% of the restricted stock units on each of August 26, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of August 26, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. (F2) The award vested as to 25% of the restricted stock units on each of August 26, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of August 26, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.